Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06828159 · ClinicalTrials.gov registry record · NA
Dietary Wild Blueberries and Joint Health
A NA study of Gut -Microbiota and Joint Pain, sponsored by University of Nevada, Las Vegas.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06828159: Recruiting NA study of Gut -Microbiota and Joint Pain, sponsored by University of Nevada, Las Vegas.
NCT06828159 is a NA study of Gut -Microbiota and Joint Pain that is actively recruiting participants, run by University of Nevada, Las Vegas. The registered enrollment target is 50 participants, above the 44-participant average among 9 other Gut -Microbiota trials with a reported enrollment target (14% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06828159, a NA study of Gut -Microbiota and Joint Pain, is actively recruiting participants, sponsored by University of Nevada, Las Vegas.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this proposed study is to examine the effects of dietary wild blueberries on gut microbiome, serum markers of inflammation, and joint function in adults. Each participant will consume 25g freeze-dried blueberries or matched placebo powder for 12 weeks, with a 2-week washout phase between.
Primary Outcome
Serum biomarkers of inflammation and cartilage degradation will be measured in the wild blueberry and placebo groups and compared for outcomes. Pain scores will also be measured using self-reported questionnaires.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Wild blueberry
Study Locations (1)
Oklahoma
- OMRF - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-09-01 |
| Est. Completion | 2028-03 |
| Phase | NA |
What NCT06828159 shows while recruiting
NCT06828159 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, above the 44-participant average among 9 other Gut -Microbiota trials with a reported enrollment target (14% higher).
The record links to 4 conditions, with Gut -Microbiota appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06828159 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT06828159 about?
NCT06828159 is a clinical study titled "Dietary Wild Blueberries and Joint Health". The goal of this proposed study is to examine the effects of dietary wild blueberries on gut microbiome, serum markers of inflammation, and joint function in adults. Each participant will consume 25g freeze-dried blueberries or matched placebo powder for 12 weeks, with a 2-week washout phase between...
What is the current status of trial NCT06828159?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-09-01. Estimated completion is 2028-03.
What conditions does trial NCT06828159 study?
This clinical trial studies the following conditions: Gut -Microbiota, Joint Pain, Inflammation Biomarkers, Pain Assessment.
What interventions are being tested in trial NCT06828159?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Wild blueberry (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06828159?
This trial is sponsored by University of Nevada, Las Vegas, which has 52 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06828159 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gut -Microbiota
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06828159's enrollment target sits among peer trials
50 4th of 9 higher than 5 of 9 other Gut -Microbiota trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gut -Microbiota trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Walnuts as an Infant Solid Food for Health
RECRUITING · NA
-
How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body Types
RECRUITING · NA
-
Peanuts for Cardiometabolic, Brain, and Intestinal Health
RECRUITING · NA
-
Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes
RECRUITING · NA
-
Gut Mini-Pill Study
RECRUITING · NA
-
Effects of Grape Powder on Psychological Distress and Gut Microbiota in College Students
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI